# Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study

**Authors:** Sonja Wurm, Jennifer M. Moritz, Verena Petzer, Dominik Wolf, Karoline V. Gleixner, Wolfgang R. Sperr, Christina Groiss, Sigrid Machherndl-Spandl, Gregor Eisenwort, Elisabeth Koller, Johannes Schoeche, Clemens Petrasch, Josef Singer, Daniel M. Mayer, Gudrun Pregartner, Annkristin Heine, Albert Wölfler, Heinz Sill, Andreas Reinisch, Armin Zebisch

PMC · DOI: 10.1038/s41408-025-01396-5 · 2025-10-22

## Full-text entities

- **Diseases:** AML (MESH:D015470)
- **Chemicals:** venetoclax (MESH:C579720)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12546751/full.md

---
Source: https://tomesphere.com/paper/PMC12546751